Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation

33Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Selective cyclooxygenase-2 (COX-2) inhibitors are widely used due to their efficacy and good safety profile. However, recent case reports have described varying degrees of liver injuries associated with the use of COX-2 inhibitors. We report the case of a patient who developed acute cholestatic hepatitis progressing to hepatic failure requiring liver transplantation, following a 3-d course of celecoxib for treatment of generalized muscle aches and pains. The clinical presentation, the laboratory data, as well as the liver histopathology were supportive of the putative diagnosis of drug induced liver injury. © 2009 The WJG Press and Baishideng. All rights reserved.

Cite

CITATION STYLE

APA

El Hajj, I. I., Malik, S. M., Alwakeel, H. R., Shaikh, O. S., Sasatomi, E., & Kandil, H. M. (2009). Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation. World Journal of Gastroenterology, 15(31), 3937–3939. https://doi.org/10.3748/wjg.15.3937

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free